NEUROMOdulation Pain Therapy in Combination With Intensive Physiotherapy
Launched by CHARLES UNIVERSITY, CZECH REPUBLIC · Sep 14, 2022
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new treatment approach for people with spinal cord injuries. The researchers want to see if combining neuromodulation therapy, which involves using a device to stimulate the spinal cord, with intensive physiotherapy can help improve movement in the lower limbs. The goal is to help patients regain mobility and improve their quality of life.
To participate in this trial, you need to have a spinal cord lesion, which is an injury to the spinal cord. Unfortunately, if you have other neurological conditions, you won't be eligible. The trial is open to individuals aged between 65 and 74, and it welcomes participants of all genders. While the trial is not yet recruiting, if you join, you can expect to undergo both the neuromodulation therapy and physiotherapy to see how it affects your mobility. This study aims to provide valuable insights that could lead to better treatments for those with spinal cord injuries in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • spinal cord lesion
- Exclusion Criteria:
- • other neurological conditions
About Charles University, Czech Republic
Charles University, located in the Czech Republic, is a prestigious institution renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive academic expertise and state-of-the-art facilities to conduct innovative research that aims to improve patient outcomes and contribute to the global medical community. With a focus on ethical standards and rigorous scientific methodologies, Charles University collaborates with various stakeholders to explore new therapies and enhance healthcare practices, fostering a culture of excellence in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Prague, , Czechia
Patients applied
Trial Officials
Kamila Řasová, assoc. prof.
Principal Investigator
Department of rehabilitation, Third Faculty of Medicine, Charles University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials